Cubist Systematic Strategies »

Neurogene shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $39k 2.3k 17.33
2024-03-31 $546k 11k 50.90

More positions owned by Cubist Systematic Strategies

Spdr Gold Tr Gold Shs (GLD)
Oracle Corporation Call Option (ORCL)
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)
Palantir Technologies Cl A Call Option (PLTR)
UnitedHealth Call Option (UNH)
Robinhood Mkts Com Cl A Call Option (HOOD)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Select Sector Spdr Tr Energy Call Option (XLE)
Nebius Group Shs Class A Call Option (NBIS)
Meta Platforms Cl A (META)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Netflix Call Option (NFLX)
Wal-Mart Stores (WMT)

View all positions for Cubist Systematic Strategies

Top funds holding Neurogene

Samsara BioCapital
Rtw Investments
Redmile Group
Casdin Capital
EcoR1 Capital
Baker Bros. Advisors
BlackRock
Balyasny Asset Management
Toronto-Dominion Bank
Vanguard Group
Arrowpoint Asset Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Jennison Associates
Octagon Capital Advisors

View all funds holding Neurogene